Dr. Angela Y. Zhu, MD

Dr. Zhu practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Zhu's NPI, 1629462866, was assigned on March 25, 2015. Dr. Zhu graduated from Cleveland Medical College, Homeopathic in 2015. Dr. Zhu holds Florida license ME140453.

Dr. Zhu's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Zhu's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Zhu to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhu practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Zhu's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Zhu is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Zhu's licenses on file in 2 states: Florida and Maryland.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and hereditary corneal conditions among the conditions Dr. Zhu treats.

CMS data shows 147 Medicare services from Dr. Zhu across 5 procedure codes in 2024, for 109 Medicare patients. Medicare paid $19,876 for them.

CMS counts 109 Medicare patients who saw Dr. Zhu in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zhu's median patient age at 70, with 60% women.

In 2024, Dr. Zhu wrote 607 Medicare Part D claims for 123 patients. 64% of them were for generic drugs. CMS names the drug for 523 of them, across 7 drugs with 11 or more claims each, at $15,836 in total drug cost. In 2023, CMS named 480 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Zhu for performance year 2024, reported as part of a group. Dr. Zhu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of cataract surgery by Dr. Zhu, more than 51% of the clinicians it reports for that procedure.

Dmand AI links 34 papers to Dr. Zhu, published from 2011 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Fuchs' Endothelial Dystrophy, Oxidative Stress and Practice Patterns, Physicians'. Dr. Zhu has published most often in Cornea. Dr. Zhu's most frequent co-authors are Albert Jun, MD, Ta Chen Peter Chang, MD and Jason Chen Fan, MD, PhD.

Dmand AI links Dr. Zhu to 1 clinical trial. Conditions studied include Corneal Injuries and Eye Injuries.

CMS Open Payments shows 113 general payments to Dr. Zhu from 25 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 73% of the total. Kedrion Biopharma, Inc. paid the most, $29,061.

Dr. Zhu graduated from Cleveland Medical College, Homeopathic in 2015.

Dr. Zhu is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.